Bicara Therapeutics Inc. Common Stock
BCAX
Rank in Stocks
#10699
Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development... Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, dual-action treatments specifically for solid tumors. At the forefront of their pipeline is ficerafusp alfa, a unique antibody designed to tackle solid cancers. This bifunctional therapeutic agent works by simultaneously engaging the epidermal growth factor receptor (EGFR) and binding to human transforming growth factor beta (TGF-b). Bicara Therapeutics operates as a subsidiary of Biocon Limited.
Share Price
$9.98
Last synced: 2026-11-09
Market Cap
$660.41M
Change (1 day)
15.38%
Change (1 year)
-32.25%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Bicara Therapeutics Inc. Common Stock (BCAX)
Category
Healthcare
EPS for Bicara Therapeutics Inc. Common Stock (BCAX)
EPS as of June 2026 TTM: $-3.10
According to Bicara Therapeutics Inc. Common Stock's latest financial reports, its current EPS (TTM) is $-3.10. At the end of 2025 the company had an EPS of $-2.52, a decrease compared to its 2024 EPS of $-1.25.
EPS history for Bicara Therapeutics Inc. Common Stock from 2022 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-3.10 | 23.02% |
| 2025 | $-2.52 | 101.60% |
| 2024 | $-1.25 | 25.00% |
| 2023 | $-1.00 | 36.99% |
| 2022 | $-0.73 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -605.16% |
US
|
|
| $-7.07 | 128.06% |
US
|
|
| $-5.29 | 70.65% |
AU
|
|
| $12.88 | -515.49% |
BE
|
|
| $21.56 | -795.48% |
NL
|
Questions about Bicara Therapeutics Inc. Common Stock's earnings per share (EPS)
What is Bicara Therapeutics Inc. Common Stock's earnings per share (EPS)?
Bicara Therapeutics Inc. Common Stock's earnings per share (EPS) over the last twelve months is $-3.10, as of Jun 2026.
What was Bicara Therapeutics Inc. Common Stock's earnings per share (EPS) in 2025?
In 2025, Bicara Therapeutics Inc. Common Stock's earnings per share (EPS) was $-2.52, compared with $-1.25 in 2024.
How has Bicara Therapeutics Inc. Common Stock's earnings per share (EPS) changed since 2022?
From 2022 to 2025, Bicara Therapeutics Inc. Common Stock's earnings per share (EPS) was highest in 2022 ($-0.73) and lowest in 2025 ($-2.52).
How does Bicara Therapeutics Inc. Common Stock's earnings per share (EPS) compare with similar companies?
Bicara Therapeutics Inc. Common Stock's earnings per share (EPS) ($-3.10) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.